{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:37:24Z","timestamp":1793795844274,"version":"4.6.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Clinical implications of reduced vancomycin susceptibility (RVS) among pediatric\n                      <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>\n                      bloodstream infections are unknown.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We identified all children at 2 children\u2019s hospitals with \u22651 blood culture positive for\n                      <jats:italic toggle=\"yes\">S. aureus<\/jats:italic>\n                      . We compared patient and clinical factors for RVS and non-RVS infections using Wilcoxon rank-sum and chi-squared tests. Treatment failure and the duration of bacteremia for RVS versus non-RVS and for methicillin-resistant\n                      <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>\n                      (MRSA) versus methicillin-susceptible\n                      <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>\n                      (MSSA) infections were compared using multivariable logistic and Poisson regressions, respectively. For MRSA infections, the association of empiric vancomycin monotherapy with treatment failure was assessed using multivariable logistic regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>RVS was present in 72% (309\/426) of cases. No patient or infection characteristics, including methicillin resistance, were associated with RVS. RVS was associated with an increased duration of bacteremia compared with non-RVS infections, aIRR = 1.15 (95% confidence interval: 1.02\u20131.30). The odds of treatment failure was similar for RVS and non-RVS infections, aOR = 1.04 (0.62\u20131.74). In contrast, MRSA infections were more likely to have treatment failure than MSSA infections, aOR = 3.03 (95% confidence interval: 1.84\u20135.00). For MRSA infections, empiric vancomycin monotherapy was associated with an increased odds of treatment failure compared with non-vancomycin or combination anti-MRSA antibiotics, aOR = 3.23 (1.12\u20139.26).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>RVS was common and was associated with a longer duration of bacteremia but not with treatment failure. Treatment failure was more common for MRSA than for MSSA bloodstream infections. Empiric vancomycin monotherapy increased the odds of treatment failure for MRSA infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000002992","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T07:00:09Z","timestamp":1605596409000},"page":"429-433","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Reduced Vancomycin Susceptibility, MRSA and Treatment Failure in Pediatric Staphylococcus aureus Bloodstream Infections"],"prefix":"10.1097","volume":"40","author":[{"given":"Ethan","family":"Canty","sequence":"first","affiliation":[{"name":"Penn State College of Medicine, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Carnahan","sequence":"additional","affiliation":[{"name":"Penn State College of Medicine, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Curley","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Children\u2019s National Hospital, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Anususinha","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Children\u2019s National Hospital, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana F.","family":"Hamdy","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Children\u2019s National Hospital, Washington, DC"},{"name":"Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Ericson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Penn State College of Medicine, Hershey, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"e1294","DOI":"10.1542\/peds.2009-2867","article-title":"Antibiotic management of Staphylococcus aureus infections in US children\u2019s hospitals, 1999-2008.","volume":"125","author":"Herigon","year":"2010","journal-title":"Pediatrics"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.","volume":"52","author":"Kullar","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bjid.2012.06.011","article-title":"Vancomycin serum concentrations in pediatric oncologic\/hematologic intensive care patients.","volume":"16","author":"Silva","year":"2012","journal-title":"Braz J Infect Dis"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/INF.0b013e3181906e40","article-title":"Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate.","volume":"28","author":"Frymoyer","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/FTD.0000000000000216","article-title":"Evaluation of vancomycin use in late-onset neonatal sepsis using the area under the concentration-time curve to the minimum inhibitory concentration \u2265400 target.","volume":"37","author":"Bhongsatiern","year":"2015","journal-title":"Ther Drug Monit"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/jpids\/pit032","article-title":"Vancomycin dosing practices, trough concentrations, and predicted area under the curve in children with suspected invasive staphylococcal infections.","volume":"2","author":"Chhim","year":"2013","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s10096-011-1228-8","article-title":"Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades.","volume":"30","author":"Ahlstrand","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.","volume":"54","author":"van Hal","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1128\/JCM.00448-13","article-title":"Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of etest and three automated testing methods.","volume":"51","author":"Rybak","year":"2013","journal-title":"J Clin Microbiol"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.cmi.2017.01.017","article-title":"Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal \u03b2-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis.","volume":"23","author":"Peric\u00e0s","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10096-009-0837-y","article-title":"Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection.","volume":"29","author":"Ferry","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/cid\/ciaa303","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.","volume":"71","author":"Rybak","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cid\/cir764","article-title":"Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.","volume":"54","author":"Moore","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/jac\/dks142","article-title":"Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.","volume":"67","author":"Docobo-P\u00e9rez","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"e20170183","DOI":"10.1542\/peds.2017-0183","article-title":"Epidemiology of methicillin-resistant Staphylococcus aureus bacteremia in children.","volume":"139","author":"Hamdy","year":"2017","journal-title":"Pediatrics"},{"key":"R18-20250615","first-page":"218","article-title":"Predictors of adverse outcomes in children with Staphylococcus aureus bacteremia.","volume":"22","author":"Kumarachandran","year":"2017","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/INF.0000000000000991","article-title":"Healthcare-associated Staphylococcus aureus bacteremia in children: evidence for reverse vancomycin creep and impact of vancomycin trough values on outcome.","volume":"35","author":"McNeil","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1128\/AAC.00658-16","article-title":"Vancomycin MIC does not predict 90-day mortality, readmission, or recurrence in a prospective cohort of adults with Staphylococcus aureus bacteremia.","volume":"60","author":"Baxi","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"e00316","DOI":"10.1128\/AAC.00316-17","article-title":"Reduced vancomycin susceptibility of methicillin-susceptible Staphylococcus aureus has no significant impact on mortality but results in an increase in complicated infection.","volume":"61","author":"Sullivan","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"R28-20250615","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S0036-46652014000600002","article-title":"Evaluation of methods in detecting vancomycin MIC among MRSA isolates and the changes in accuracy related to different MIC values.","volume":"56","author":"Rossatto","year":"2014","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/SMJ.0b013e3181efb5b1","article-title":"Vancomycin MIC susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates: a comparison between Etest\u00ae and an automated testing method.","volume":"103","author":"Bland","year":"2010","journal-title":"South Med J"},{"key":"R29-20250615","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1128\/JCM.00221-09","article-title":"Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus.","volume":"47","author":"Swenson","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijantimicag.2008.05.007","article-title":"Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.","volume":"32","author":"Hsu","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"R30-20250615","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/jir270","article-title":"Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations.","volume":"204","author":"Holmes","year":"2011","journal-title":"J Infect Dis"},{"key":"R31-20250615","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1099\/jmm.0.000988","article-title":"Reduced vancomycin susceptibility and increased macrophage survival in Staphylococcus aureus strains sequentially isolated from a bacteraemic patient during a short course of antibiotic therapy.","volume":"68","author":"Basco","year":"2019","journal-title":"J Med Microbiol"},{"key":"R32-20250615","doi-asserted-by":"crossref","first-page":"e00084","DOI":"10.1128\/AAC.00084-18","article-title":"Association of vancomycin MIC and molecular characteristics with clinical outcomes in methicillin-susceptible Staphylococcus aureus acute hematogenous osteoarticular infections in children.","volume":"62","author":"Kok","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"R33-20250615","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1684-1182(10)60073-4","article-title":"Clinical characteristics and risk factors for mortality in patients with meningitis caused by Staphylococcus aureus and vancomycin minimal inhibitory concentrations against these isolates.","volume":"43","author":"Huang","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"key":"R34-20250615","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1093\/jac\/dkv133","article-title":"Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?","volume":"70","author":"L\u00f3pez-Cort\u00e9s","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R35-20250615","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1017\/ice.2015.323","article-title":"Determinants of outcome in hospitalized patients with methicillin-resistant Staphylococcus aureus bloodstream infection: results from National Surveillance in Canada, 2008-2012.","volume":"37","author":"Simor","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R36-20250615","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jpeds.2018.12.002","article-title":"Risk factors for complications in children with Staphylococcus aureus bacteremia.","volume":"208","author":"Hamdy","year":"2019","journal-title":"J Pediatr"},{"key":"R37-20250615","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamapediatrics.2015.2380","article-title":"Burden of invasive Staphylococcus aureus infections in hospitalized infants.","volume":"169","author":"Ericson","year":"2015","journal-title":"JAMA Pediatr"},{"key":"R38-20250615","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/INF.0000000000000850","article-title":"Survival benefit of empirical therapy for Staphylococcus aureus bloodstream infections in infants.","volume":"34","author":"Thaden","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R39-20250615","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/cid\/ciy495","article-title":"Vancomycin monotherapy may be insufficient to treat methicillin-resistant Staphylococcus aureus coinfection in children with influenza-related critical illness.","volume":"68","author":"Randolph","year":"2019","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T12:04:52Z","timestamp":1749989092000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002992","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,13]]}}}